Please assess the completion status of the following clinical trial:

Trial Title: In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).~2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy~3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.~4. be able and willing to adhere to the instructions set forth in the protocol.~5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.~6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes~7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.~8. be in good general health, based on his/her knowledge.~9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.~Exclusion Criteria:~1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.~2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.~3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).~4. Slit lamp findings that would contraindicate contact lens wear such as:~   * Pathological dry eye or associated findings~  * Pterygium or corneal scars within the visual axis~  * Neovascularization \>1mm in from the limbus~  * History of giant papillary conjunctivitis (GPC) worse than Grade 2~  * Anterior uveitis or iritis (past or present)~  * Seborrhoeic eczema, seborrhoeic conjunctivitis~5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.~6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)~7. Aphakia, keratoconus or a highly irregular cornea.~8. Current pregnancy or lactation (to the best of the subject's knowledge).~9. Active participation in another clinical study at any time during this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- senofilcon A/alphafilcon A/etafilcon A (Type: ACTIVE_COMPARATOR): First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
- alphafilcon A/etafilcon A/senofilcon A (Type: ACTIVE_COMPARATOR): First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses
- etafilcon A/senofilcon A/alphafilcon A (Type: ACTIVE_COMPARATOR): First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses
- senofilcon A/etafilcon A/alphafilcon A (Type: ACTIVE_COMPARATOR): First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses
- alphafilcon A/senofilcon A/etafilcon A (Type: ACTIVE_COMPARATOR): First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
- etafilcon A/alphafilcon A/senofilcon A (Type: ACTIVE_COMPARATOR): First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete